Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9778116rdf:typepubmed:Citationlld:pubmed
pubmed-article:9778116lifeskim:mentionsumls-concept:C0949666lld:lifeskim
pubmed-article:9778116lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:9778116lifeskim:mentionsumls-concept:C1569637lld:lifeskim
pubmed-article:9778116pubmed:issue9lld:pubmed
pubmed-article:9778116pubmed:dateCreated1998-12-18lld:pubmed
pubmed-article:9778116pubmed:abstractTextA case of oxyphilic cell variant of endometrioid adenocarcinoma is presented. To the best of our knowledge, there have been only three such cases reported in the English literature. The patient was a 35-year-old Japanese female (gravida 0, para 0). She was slightly obese with profuse vaginal bleeding. Histological examination of the resected uterus revealed endometrioid adenocarcinoma with an exclusive oxyphilic cell component. There was no evidence of myometrial invasion nor lymph node metastases. Reported cases of oxyphilic cell variant of endometrioid adenocarcinoma, including the present case, were stages 0-1 and grades 1-2. Although further study is necessary to evaluate this variant, oxyphilic cell variant seems to be an early stage of adenocarcinoma and should be differentiated from eosinophilic metaplasia and other types of adenocarcinoma of the endometrium.lld:pubmed
pubmed-article:9778116pubmed:languageenglld:pubmed
pubmed-article:9778116pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9778116pubmed:citationSubsetIMlld:pubmed
pubmed-article:9778116pubmed:statusMEDLINElld:pubmed
pubmed-article:9778116pubmed:monthSeplld:pubmed
pubmed-article:9778116pubmed:issn1320-5463lld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:ShimizuMMlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:FujiwaraKKlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:ManabeTTlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:FukuokaKKlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:ShintakuMMlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:HirokawaMMlld:pubmed
pubmed-article:9778116pubmed:authorpubmed-author:KohnoIIlld:pubmed
pubmed-article:9778116pubmed:issnTypePrintlld:pubmed
pubmed-article:9778116pubmed:volume48lld:pubmed
pubmed-article:9778116pubmed:ownerNLMlld:pubmed
pubmed-article:9778116pubmed:authorsCompleteYlld:pubmed
pubmed-article:9778116pubmed:pagination754-6lld:pubmed
pubmed-article:9778116pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:meshHeadingpubmed-meshheading:9778116-...lld:pubmed
pubmed-article:9778116pubmed:year1998lld:pubmed
pubmed-article:9778116pubmed:articleTitleOxyphilic cell variant of endometrioid adenocarcinoma.lld:pubmed
pubmed-article:9778116pubmed:affiliationDepartment of Pathology, Kawasaki Medical School, Kurashiki, Okayama, Japan. hirokawa@med.kawasaki-m.ac.jplld:pubmed
pubmed-article:9778116pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9778116pubmed:publicationTypeCase Reportslld:pubmed